A meta-analysis published in the Journal of the American Heart Association last week suggested that patients treated with paclitaxel-coated balloons and stents for peripheral artery disease could be at a higher risk for late death compared to people treated with uncoated balloons.
The results of the study prompted investigators for two trials to stop their studies. Meanwhile, leaders in the endovascular community have promised to hold a special forum to discuss the study’s findings.
Get the full story at our sister site, Drug Delivery Business News.
The post Investigators hit pause on trials following concerns over paclitaxel-coated devices appeared first on MassDevice.